SlideShare a Scribd company logo
CASE PRESENTATION
Presented by
Afreen Nasir
4th PHARM.D
REG NO. 17QO902
ABMRCP
PATIENT DEMOGRAPHY
IP No. : 071900715 DOA : 6/12/19 DOD : 11/2/2020
Age : 47 YEARS Ward : 4th Department : Medicine
Sex : Female
SUBJECTIVE DATA
COMPLAINTS ON ADMISSION:
• C/o cough since 1month, fever since 15days, headache for 4 days, vomiting for
2 days, slurring of speech for 2 days.
HISTORY OF PRESENT ILLNESS :
• Patient was apparently well 1 month back, then she developed cough gradual
in onset & progressive, with scanty expectoration –mucoid, nonblood tinged,
fever –intermittent during evening with chills ,rigor, myalgia, headache-
holocranial throughout the day.
• H/O weight loss, vomiting (projectile, non bolus , contain food particles), chest
pain.
• No H/O bleeding manifestation and chest pain.
PATIENT HISTORY:
• Past medical History -
No H/O HTN , T2DM , COPD
K/C/O retroviral disease
Opportunistic infection – oral candidiasis
• Family History – Nothing significant
• Allergy - NKA
• Medication history - Nothing significant
• Social History -
Appetite: Reduce Sleep: disturb Bowel-Bladder: Normal &regular
Diet: Mixed
• Past Menopausal – 2 yr
OBJECTIVE DATA
• VITAL SIGNS :(6/12/19)
BP : 140/80mmHg RR: 90 breaths /min SPO2=96%
• GENERAL EXAMINATION: Patient is moderately built , well nourished
PICCKLE : Pallor + ,Icterus / Cyanosis/ Clubbing/Koilonychia / Lymphadenopathy/Oedema – Absent
• SYSTEMIC EXAMINATION
HEENT – normal
CNS- conscious , well oriented to time /place/person ,HMF +
RS- normal breath sound
Par abdomen – soft
CVS- S1 S2 sound +, Tachycardia
Power- 5/5 5/5 Tone – N N Plantar - ↓
5/5 5/5 N N
Neck stiffness + Kernig's sign + Brudzinski's sign +
PROVISIONAL DIAGNOSIS:
• Δes PLHA ( person living HIV – AIDS) to rule out Opportunistic infection, oral
candidiasis
• Δes Retroviral disease +
LABORATORY EXAMINATION:
Tests Performed 7/12 30/12 23/1 10/2 Normal values
Hemogram
Hgb 6.2 9.5 10.4 10.2 F= 12.3-15.5 g/dL
PCV 20.4 21.2 30.2 30.1 F = 36-45%
RBC 1.94 3.56 3.60 3.62 F = 3.5 – 4.5 × 10⁵ / mm³
Platelets 3.7 3.34 3.70 3.78 1.5-4.5 lakhs/mm³
MCH 30 31 29 29.2 27-32 pg / cell
MCV 92.7 90 87.5 84.8 80-96 fL
MCHC 34.9 32 30.1 30.4 33 – 35.5 g/dL
ESR 135 110 F= 1-20 mm /hr
WBC 5900 6100 5300 7900 4000-11000/mm³
Neutrophils 50 59 48 65 45-73%
Eosinophils 12 8 8.6 7 0-4%
Lymphocytes 29 27 24 31 20-40%
Basophils 00 00 0.8 00 0-1 %
Monocytes 10 8 14 12 2-8%
Tests Performed 7/12 30/12 23/1 10/2 Normal values
VitB12 118 121 150 178 180- 914 pg/ml
Ferritin 694 630 599 594 F= 11-307 ng/ml
Sr.Iron 206 200 201 200 F= 37- 145 microgram / dL
Transferrin 196 190 189 195 200 – 300 mg/dL
Absolute eosinophilic count 660 590 40-440 / mm³
Transferrin Saturation 81.2 81 79 80 20-50%
UIBC 48 50 50.9 51 112-346 microgram/dL
TIBC 254 255 254 250-450 microgram/dL
Lipid Profile : LDL 224 <130mg/GL
RFT
S. creatinine 1.3 1.0 1.2 0.8 F= 0.5-0.9 mg/dL
BUN 27 22 21 20 7-20 mg/dl
Sr. Sodium 124 129 132 137 136-145 mEq/L
Sr .Potassium 5.5 5.0 5.2 4.9 3.5 – 5.1 mEq/L
Sr. Chloride 95 96 98 95 97-114 mEq/L
Tests Performed 7/12 30/12 23/1 10/2 Normal values
LFT
Albumin 3.4 4.8 4.8 5.1 3.5-5.5g/dL
Globulin 5.5 5.4 5.3 4.6 2.5-4.5 g/dL
ALP 179 175 178 112 30-120 unit/L
SGOT/AST 52 52.1 49 39 10-35 U/L
SGPT /ALT 36 35 36 37 <35 U/L
T. Bilirubin 1.2 1.3 Up to 1.2 mg/L
Sr. Direct bilirubin 0.6 0.5 0.30 0.2 mg/dL
GGT 244 219 117 1-94 U/L
PT 10.3 11.1 – 13.1 sec
INR 0.91 0.9-1.1
Impression – Normochromic, normocytic anemia with eosinophilia
OTHER TESTS (30/12/19)-
• Cytology report : 0.5 ml CSF was collected which was colourless & clear in appearance . 47cells/mm³ cells
were counted in CSF in which lymphocytes were 90% predominantly & neutrophils 10%
• Urine analyses : amorphous granules present
FINAL DIAGNOSIS:
• Patient is diagnosed with Cryptococcal meningitis and oral candidiasis .
TREATMENT CHART :
• Medicine
• prescribed
• Generic name
• Dose
• Freq
• Route
• Indications
• Start date
• Stop date
Medicine
prescribed
Generic name Dose Freq Route Indications Start
date
Stop
date
Inj .Ceftriaxone CEFTRIAXONE • 1g
• 17,30/12
(2g)
1-0-0
1-0-1
7/1 (1-0-1)
IV Antibiotic to treat
respiratory
infection
16/12 10/1
C. Fluconazole FLUCONAZOLE • 150mg
• 300mg
• 150mg
• 250mg
 (1-0-0)
• 7/1 (1-0-1)
 18/1 (1-1-1)
• 19 , 20/1 (1-1-1-1)
 21/1 (1-0-1)
 24 - 27/1 (1-0-1)
p/o Antifungal for
meningitis
16/12-
10/1
28/1
6/2
Inj. PAN PANTOPRAZOLE 40mg 1-0-0 IV Proton pump inh
– Treat acid reflex
16/12 6/2
Inj .Emeset ONDANSETRON 4g • 1-0-1
• 28/1 (1-1-1)
IV antiemetic ’’ ’’
T. Fe FERROUS
SULPHATE
• 200mg 0-1-0 p/o Treat anemia 1/2 11/2
Medicine
prescribed
Generic name Dose Freq Route Indications Start
date
Stop
date
Inj. Paracetamol ACETAMINOPHEN • 1g
• 6,7/ 1 : (500mg)
SOS IV Analgesic,
antipyretic
16/12
10/2
16/1
-
T. Septran DS TRIMETHOPRIM
(80mg)/SULFAMETHOX
AZOLE(400mg)
1-0-0 p/o Antibiotic 30/12
20/1
10/1
11/2
Inj . Mannitol MANNITOL 1-0-1
• 31/12(1-1-1)
IV Osmotic diuretic –
Treat meningitis
30/12 4/1
Inj . Amphotericin
. B. Liposomal
AMPHOTERICIN B 240mg
• 8/1 (45mg/d)
1-0-0 in 5% D
flush NS
IV Antifungal –treat
cryptococcal
meningitis
4/1
20/1
16/1
6/2
T. Candid V3 CLOTRIMAZOLE 200mg 0-0-1 p/o Antifungal – oral
candidiasis
4/1 -
Candid mouth 1%
paint
CLOTRIMAZOLE Antifungal – treat
oral thrush
16/12
2/1
31/12
11/1
T. PCT ACETAMINOPHEN 500mg 1-1-1 P/O Antipyretic ,
analgesic
11/1
24/1
26/1
31/1
3/2
21/1
-
29/1
-
6/2 -
9/2
Medicine
prescribed
Generic name Dose Freq Route Indications Start
date
Stop
date
Syp. Ambrolite AMBROXOL+
GUAIFENESIN + TERBUTALINE + METHANOL
10ml– 2tsp 1-1-1 p/o Mucolytic 5/2 8/2
T. N . Acetyl
cysteine
ACETYLCYSTEINE 600mg 1-1-1 p/o Mucolytic 16/12 2/2
Inj. Optineuron Cyanocobalamin (B12)1000mcg, D-Panthenol (Vit
B5) 5omg, Pyridoxine (Vit B6) 100 mg, Riboflavin
(Vit B2)5mg, Thiamine(vit B1) 100mg,
Nicotinamide (vit B3) 100mg
1 amp in 100
ml NS
• 1/2
(2amp)
0-1-0 IV Treat VitB12
deficiency- vit
supplement
20/1
1/2
11/2
21/1
-
-
T. Bifilac Lactobacillus 50 million spores+ Streptococcus
faecalis 30million+ Clostridium butyricum
2million + Bacillus mesentericus 1 million
2-2-2 p/o Probiotic 1/2 11/2
IVF .NS
RL
NORMAL SALINE
RINGER LACTATE
1 pint
1 pint
• 19/1
( 100mg/L)
1-0-0 IV Electrolyte
replenisher
16/12
19/1
17/12
-
IVF .DNS DEXTROSE , SODIUM CHLORIDE • 1 Pint @
75 ml/hr
• 1 pint @
100ml /hr
’’ ’’ 3/1
30/12
-
8/1
ASSESSMENT
TREATMENT GOALS:
• Patient specific –
-Improve QOL
-Selecting cost effective medicine & minimizing side effects of medicines
• Disease specific –
- Eradication of microorganism causing infection , reducing sign – symptoms
- Prevention of neurologic sequelae like seizure , deafness, coma, death
- Identifying microbes in CSF & destroying them
PROGRESS CHART:
Date BP (mmHg) Pulse
(Beats/min)
SPO2 Complaints Notes
17/12 110/70 84 98% Neck stiffness + CVS : S1S2+
RS : NVBS
PA : soft NT
30/12 110/70 92 98% Drowsiness
31/12 130/80 70 93% Drowsiness , neck stiffness +
1/1 90/60 90 95%
2/1 90/60 100 94% Fever (100.4º) with headache , 1 epi vomiting
3/1 100/60 98 94% 1 epi fever, 2 epi vomiting
13/1 110/70 98 98% Headache
16/1 120/70 98 96% Nausea , headache
22/1 100/80 90 97% Headache, 1epi vomit
23/1 180/70 112 96% Headache, 2 epi vomit with blood tinged
26/1 110/70 94 94% headache
28/1 130/80 110 97% headache
30/1 100/80 118 99% SOB
Date BP (mmHg) Pulse
(Beats/min)
SPO2 Complaints Notes
1/2 110/70 110 96% 1 pint PRBC transfusion ( O +ve)
2/2 120/80 116 96% fatigability ’’
3/2 120/80 120 96% ’’
4/2 ” 114 98% headache ’’
8/2 130/90 124 ”
9/2 120/80 88 ” 1 epi vomiting
10/2 110/70 120 ” headache
11/2 100/70 100 ” ’’
CLINICAL PHARMACIST NOTES / INTERVENTION:
• Drug – drug interaction :
1) Serious – Fluconazole + ondansetron - ↑ QTc interval
2) Monitor closely-
Pan ↓ effect of ferrous sulphate by ↑ gastric pH
Fluconazole & Trimethoprim ↑ QTc interval
3) Minor-
Pan ↓ level of cyanocobalamin
Fluconazole ↑ level / effect of sulfamethoxazole
Fluconazole↑ level / effect of pan
PLAN
CONDITION ON DISCHARGE-
• Pallor +
• Power, tone, reflex –N
• BP- 140/80mmHg
• SPO₂ - 96%
• PR- 90 BPM
• CVS – S1S2 ,Tachycardia +
• RS- NVBS
• CNS – Conscious, Kernig's + , Brudzinski's + , Neck stiffness +
ADVICE TO DOCTOR-
Since the patient’s discharge condition is not stable as sign –symptoms of meningitis are still
present , and there is no discharge medicine prescribed for that, may be her conditions can
improve if C. FLUCONAZOLE 250 mg is included in her discharge medicine.
DISCHARGE MEDICATION :
Medicine prescribed Generic name Dose Frequency/ Duration Possible side effects
T. Septran DS TRIMETHOPRIM
(80mg)+
SULFAMETHOXAZOLE
(400mg)
1-0-0 × 1 week diarrhea , skin rashes, headache
T. PAN PANTOPRAZOLE 40mg 1-0-0 × 1 week vomit, constipation, gas formation in
stomach, loose motion, fast heart beat
T.PCT PARACETAMOL (
ACETAMINOPHEN)
500mg 0-0-1 × 1 week stomach pain , ulcer in mouth
T. Optineurin Vit – B 12,B5, B6,B2,
B3, B1
0-1-0 × 1 week Headache , sleepiness, upset stomach
T.Fe FERROUS SULPHATE 200mg 0-1-1 × 30 days constipation/ loose motion , dark color
stool
T. N . Acetylcysteine ACETYLCYSTEINE 600 mg 1-1-1 × 30 days Vomit, mouth sore
PATIENT COUNSELLING:
• Disease
• Medication
• Diet
• Lifestyle modification

More Related Content

Similar to Case Presentation: Cryptococcal meningitis

13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
Dr. Ajita Sadhukhan
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Akshaya M
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
glyf26shai
 
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptxSinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
SyahrulAdzim
 
Mendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseasesMendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseases
Chulalongkorn Allergy and Clinical Immunology Research Group
 
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASESAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SaiDeepakS1
 
a case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAAa case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAA
ZIKRULLAH MALLICK
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
Bng Crz
 
Case history
Case historyCase history
Case history
drfarhanali2008
 
vonwillebrand disease type 1 case
vonwillebrand disease type 1    case vonwillebrand disease type 1    case
vonwillebrand disease type 1 case
drfarhanali2008
 
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek TantawyCase Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
Ahmed Albeyaly
 
Fever with rash
Fever with rashFever with rash
Fever with rash
BINOD BISWAJEET ROUT
 
Case Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptxCase Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptx
Joel M Johns
 
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
Dr. Ajita Sadhukhan
 
A young woman with lupus
A young woman with lupusA young woman with lupus
A young woman with lupus
Enida Xhaferi
 
pnemonia.pptx
pnemonia.pptxpnemonia.pptx
pnemonia.pptx
Amar Prasad
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
YuyunRasulong1
 
Case presentation on renal caliculi
Case presentation on renal caliculiCase presentation on renal caliculi
Case presentation on renal caliculi
SaiSwapna3
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGs
CSN Vittal
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
Kyle Crisco
 

Similar to Case Presentation: Cryptococcal meningitis (20)

13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoea
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptxSinus Bradicardia on grade II dengue hemorragic fever.pptx
Sinus Bradicardia on grade II dengue hemorragic fever.pptx
 
Mendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseasesMendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseases
 
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASESAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
 
a case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAAa case of abdominal aorta aneurysm-- AAA
a case of abdominal aorta aneurysm-- AAA
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
 
Case history
Case historyCase history
Case history
 
vonwillebrand disease type 1 case
vonwillebrand disease type 1    case vonwillebrand disease type 1    case
vonwillebrand disease type 1 case
 
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek TantawyCase Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
Case Presentation Dr. Hosam Fouda Supervised by Dr. Tarek Tantawy
 
Fever with rash
Fever with rashFever with rash
Fever with rash
 
Case Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptxCase Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptx
 
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
 
A young woman with lupus
A young woman with lupusA young woman with lupus
A young woman with lupus
 
pnemonia.pptx
pnemonia.pptxpnemonia.pptx
pnemonia.pptx
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
 
Case presentation on renal caliculi
Case presentation on renal caliculiCase presentation on renal caliculi
Case presentation on renal caliculi
 
Acute glomerulonephritis for UGs
Acute glomerulonephritis for UGsAcute glomerulonephritis for UGs
Acute glomerulonephritis for UGs
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
 

More from Dr. Afreen Nasir

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
Dr. Afreen Nasir
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
Dr. Afreen Nasir
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
Dr. Afreen Nasir
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Dr. Afreen Nasir
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
Dr. Afreen Nasir
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
Dr. Afreen Nasir
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
Dr. Afreen Nasir
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
Dr. Afreen Nasir
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
Dr. Afreen Nasir
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
Dr. Afreen Nasir
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
Dr. Afreen Nasir
 
Journal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICUJournal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICU
Dr. Afreen Nasir
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
Dr. Afreen Nasir
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
Dr. Afreen Nasir
 
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Dr. Afreen Nasir
 

More from Dr. Afreen Nasir (17)

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
 
Journal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICUJournal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICU
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
 
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
 

Recently uploaded

2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
MiadAlsulami
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
MianProductions
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
ChetanSharma78255
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
gjsma0ep
 

Recently uploaded (20)

2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
 

Case Presentation: Cryptococcal meningitis

  • 1. CASE PRESENTATION Presented by Afreen Nasir 4th PHARM.D REG NO. 17QO902 ABMRCP
  • 2. PATIENT DEMOGRAPHY IP No. : 071900715 DOA : 6/12/19 DOD : 11/2/2020 Age : 47 YEARS Ward : 4th Department : Medicine Sex : Female
  • 3. SUBJECTIVE DATA COMPLAINTS ON ADMISSION: • C/o cough since 1month, fever since 15days, headache for 4 days, vomiting for 2 days, slurring of speech for 2 days. HISTORY OF PRESENT ILLNESS : • Patient was apparently well 1 month back, then she developed cough gradual in onset & progressive, with scanty expectoration –mucoid, nonblood tinged, fever –intermittent during evening with chills ,rigor, myalgia, headache- holocranial throughout the day. • H/O weight loss, vomiting (projectile, non bolus , contain food particles), chest pain. • No H/O bleeding manifestation and chest pain.
  • 4. PATIENT HISTORY: • Past medical History - No H/O HTN , T2DM , COPD K/C/O retroviral disease Opportunistic infection – oral candidiasis • Family History – Nothing significant • Allergy - NKA • Medication history - Nothing significant • Social History - Appetite: Reduce Sleep: disturb Bowel-Bladder: Normal &regular Diet: Mixed • Past Menopausal – 2 yr
  • 5. OBJECTIVE DATA • VITAL SIGNS :(6/12/19) BP : 140/80mmHg RR: 90 breaths /min SPO2=96% • GENERAL EXAMINATION: Patient is moderately built , well nourished PICCKLE : Pallor + ,Icterus / Cyanosis/ Clubbing/Koilonychia / Lymphadenopathy/Oedema – Absent • SYSTEMIC EXAMINATION HEENT – normal CNS- conscious , well oriented to time /place/person ,HMF + RS- normal breath sound Par abdomen – soft CVS- S1 S2 sound +, Tachycardia Power- 5/5 5/5 Tone – N N Plantar - ↓ 5/5 5/5 N N Neck stiffness + Kernig's sign + Brudzinski's sign +
  • 6. PROVISIONAL DIAGNOSIS: • Δes PLHA ( person living HIV – AIDS) to rule out Opportunistic infection, oral candidiasis • Δes Retroviral disease +
  • 7. LABORATORY EXAMINATION: Tests Performed 7/12 30/12 23/1 10/2 Normal values Hemogram Hgb 6.2 9.5 10.4 10.2 F= 12.3-15.5 g/dL PCV 20.4 21.2 30.2 30.1 F = 36-45% RBC 1.94 3.56 3.60 3.62 F = 3.5 – 4.5 × 10⁵ / mm³ Platelets 3.7 3.34 3.70 3.78 1.5-4.5 lakhs/mm³ MCH 30 31 29 29.2 27-32 pg / cell MCV 92.7 90 87.5 84.8 80-96 fL MCHC 34.9 32 30.1 30.4 33 – 35.5 g/dL ESR 135 110 F= 1-20 mm /hr WBC 5900 6100 5300 7900 4000-11000/mm³ Neutrophils 50 59 48 65 45-73% Eosinophils 12 8 8.6 7 0-4% Lymphocytes 29 27 24 31 20-40% Basophils 00 00 0.8 00 0-1 % Monocytes 10 8 14 12 2-8%
  • 8. Tests Performed 7/12 30/12 23/1 10/2 Normal values VitB12 118 121 150 178 180- 914 pg/ml Ferritin 694 630 599 594 F= 11-307 ng/ml Sr.Iron 206 200 201 200 F= 37- 145 microgram / dL Transferrin 196 190 189 195 200 – 300 mg/dL Absolute eosinophilic count 660 590 40-440 / mm³ Transferrin Saturation 81.2 81 79 80 20-50% UIBC 48 50 50.9 51 112-346 microgram/dL TIBC 254 255 254 250-450 microgram/dL Lipid Profile : LDL 224 <130mg/GL RFT S. creatinine 1.3 1.0 1.2 0.8 F= 0.5-0.9 mg/dL BUN 27 22 21 20 7-20 mg/dl Sr. Sodium 124 129 132 137 136-145 mEq/L Sr .Potassium 5.5 5.0 5.2 4.9 3.5 – 5.1 mEq/L Sr. Chloride 95 96 98 95 97-114 mEq/L
  • 9. Tests Performed 7/12 30/12 23/1 10/2 Normal values LFT Albumin 3.4 4.8 4.8 5.1 3.5-5.5g/dL Globulin 5.5 5.4 5.3 4.6 2.5-4.5 g/dL ALP 179 175 178 112 30-120 unit/L SGOT/AST 52 52.1 49 39 10-35 U/L SGPT /ALT 36 35 36 37 <35 U/L T. Bilirubin 1.2 1.3 Up to 1.2 mg/L Sr. Direct bilirubin 0.6 0.5 0.30 0.2 mg/dL GGT 244 219 117 1-94 U/L PT 10.3 11.1 – 13.1 sec INR 0.91 0.9-1.1 Impression – Normochromic, normocytic anemia with eosinophilia OTHER TESTS (30/12/19)- • Cytology report : 0.5 ml CSF was collected which was colourless & clear in appearance . 47cells/mm³ cells were counted in CSF in which lymphocytes were 90% predominantly & neutrophils 10% • Urine analyses : amorphous granules present
  • 10. FINAL DIAGNOSIS: • Patient is diagnosed with Cryptococcal meningitis and oral candidiasis .
  • 11. TREATMENT CHART : • Medicine • prescribed • Generic name • Dose • Freq • Route • Indications • Start date • Stop date Medicine prescribed Generic name Dose Freq Route Indications Start date Stop date Inj .Ceftriaxone CEFTRIAXONE • 1g • 17,30/12 (2g) 1-0-0 1-0-1 7/1 (1-0-1) IV Antibiotic to treat respiratory infection 16/12 10/1 C. Fluconazole FLUCONAZOLE • 150mg • 300mg • 150mg • 250mg  (1-0-0) • 7/1 (1-0-1)  18/1 (1-1-1) • 19 , 20/1 (1-1-1-1)  21/1 (1-0-1)  24 - 27/1 (1-0-1) p/o Antifungal for meningitis 16/12- 10/1 28/1 6/2 Inj. PAN PANTOPRAZOLE 40mg 1-0-0 IV Proton pump inh – Treat acid reflex 16/12 6/2 Inj .Emeset ONDANSETRON 4g • 1-0-1 • 28/1 (1-1-1) IV antiemetic ’’ ’’ T. Fe FERROUS SULPHATE • 200mg 0-1-0 p/o Treat anemia 1/2 11/2
  • 12. Medicine prescribed Generic name Dose Freq Route Indications Start date Stop date Inj. Paracetamol ACETAMINOPHEN • 1g • 6,7/ 1 : (500mg) SOS IV Analgesic, antipyretic 16/12 10/2 16/1 - T. Septran DS TRIMETHOPRIM (80mg)/SULFAMETHOX AZOLE(400mg) 1-0-0 p/o Antibiotic 30/12 20/1 10/1 11/2 Inj . Mannitol MANNITOL 1-0-1 • 31/12(1-1-1) IV Osmotic diuretic – Treat meningitis 30/12 4/1 Inj . Amphotericin . B. Liposomal AMPHOTERICIN B 240mg • 8/1 (45mg/d) 1-0-0 in 5% D flush NS IV Antifungal –treat cryptococcal meningitis 4/1 20/1 16/1 6/2 T. Candid V3 CLOTRIMAZOLE 200mg 0-0-1 p/o Antifungal – oral candidiasis 4/1 - Candid mouth 1% paint CLOTRIMAZOLE Antifungal – treat oral thrush 16/12 2/1 31/12 11/1 T. PCT ACETAMINOPHEN 500mg 1-1-1 P/O Antipyretic , analgesic 11/1 24/1 26/1 31/1 3/2 21/1 - 29/1 - 6/2 - 9/2
  • 13. Medicine prescribed Generic name Dose Freq Route Indications Start date Stop date Syp. Ambrolite AMBROXOL+ GUAIFENESIN + TERBUTALINE + METHANOL 10ml– 2tsp 1-1-1 p/o Mucolytic 5/2 8/2 T. N . Acetyl cysteine ACETYLCYSTEINE 600mg 1-1-1 p/o Mucolytic 16/12 2/2 Inj. Optineuron Cyanocobalamin (B12)1000mcg, D-Panthenol (Vit B5) 5omg, Pyridoxine (Vit B6) 100 mg, Riboflavin (Vit B2)5mg, Thiamine(vit B1) 100mg, Nicotinamide (vit B3) 100mg 1 amp in 100 ml NS • 1/2 (2amp) 0-1-0 IV Treat VitB12 deficiency- vit supplement 20/1 1/2 11/2 21/1 - - T. Bifilac Lactobacillus 50 million spores+ Streptococcus faecalis 30million+ Clostridium butyricum 2million + Bacillus mesentericus 1 million 2-2-2 p/o Probiotic 1/2 11/2 IVF .NS RL NORMAL SALINE RINGER LACTATE 1 pint 1 pint • 19/1 ( 100mg/L) 1-0-0 IV Electrolyte replenisher 16/12 19/1 17/12 - IVF .DNS DEXTROSE , SODIUM CHLORIDE • 1 Pint @ 75 ml/hr • 1 pint @ 100ml /hr ’’ ’’ 3/1 30/12 - 8/1
  • 14. ASSESSMENT TREATMENT GOALS: • Patient specific – -Improve QOL -Selecting cost effective medicine & minimizing side effects of medicines • Disease specific – - Eradication of microorganism causing infection , reducing sign – symptoms - Prevention of neurologic sequelae like seizure , deafness, coma, death - Identifying microbes in CSF & destroying them
  • 15. PROGRESS CHART: Date BP (mmHg) Pulse (Beats/min) SPO2 Complaints Notes 17/12 110/70 84 98% Neck stiffness + CVS : S1S2+ RS : NVBS PA : soft NT 30/12 110/70 92 98% Drowsiness 31/12 130/80 70 93% Drowsiness , neck stiffness + 1/1 90/60 90 95% 2/1 90/60 100 94% Fever (100.4º) with headache , 1 epi vomiting 3/1 100/60 98 94% 1 epi fever, 2 epi vomiting 13/1 110/70 98 98% Headache 16/1 120/70 98 96% Nausea , headache 22/1 100/80 90 97% Headache, 1epi vomit 23/1 180/70 112 96% Headache, 2 epi vomit with blood tinged 26/1 110/70 94 94% headache 28/1 130/80 110 97% headache 30/1 100/80 118 99% SOB
  • 16. Date BP (mmHg) Pulse (Beats/min) SPO2 Complaints Notes 1/2 110/70 110 96% 1 pint PRBC transfusion ( O +ve) 2/2 120/80 116 96% fatigability ’’ 3/2 120/80 120 96% ’’ 4/2 ” 114 98% headache ’’ 8/2 130/90 124 ” 9/2 120/80 88 ” 1 epi vomiting 10/2 110/70 120 ” headache 11/2 100/70 100 ” ’’
  • 17. CLINICAL PHARMACIST NOTES / INTERVENTION: • Drug – drug interaction : 1) Serious – Fluconazole + ondansetron - ↑ QTc interval 2) Monitor closely- Pan ↓ effect of ferrous sulphate by ↑ gastric pH Fluconazole & Trimethoprim ↑ QTc interval 3) Minor- Pan ↓ level of cyanocobalamin Fluconazole ↑ level / effect of sulfamethoxazole Fluconazole↑ level / effect of pan
  • 18. PLAN CONDITION ON DISCHARGE- • Pallor + • Power, tone, reflex –N • BP- 140/80mmHg • SPO₂ - 96% • PR- 90 BPM • CVS – S1S2 ,Tachycardia + • RS- NVBS • CNS – Conscious, Kernig's + , Brudzinski's + , Neck stiffness + ADVICE TO DOCTOR- Since the patient’s discharge condition is not stable as sign –symptoms of meningitis are still present , and there is no discharge medicine prescribed for that, may be her conditions can improve if C. FLUCONAZOLE 250 mg is included in her discharge medicine.
  • 19. DISCHARGE MEDICATION : Medicine prescribed Generic name Dose Frequency/ Duration Possible side effects T. Septran DS TRIMETHOPRIM (80mg)+ SULFAMETHOXAZOLE (400mg) 1-0-0 × 1 week diarrhea , skin rashes, headache T. PAN PANTOPRAZOLE 40mg 1-0-0 × 1 week vomit, constipation, gas formation in stomach, loose motion, fast heart beat T.PCT PARACETAMOL ( ACETAMINOPHEN) 500mg 0-0-1 × 1 week stomach pain , ulcer in mouth T. Optineurin Vit – B 12,B5, B6,B2, B3, B1 0-1-0 × 1 week Headache , sleepiness, upset stomach T.Fe FERROUS SULPHATE 200mg 0-1-1 × 30 days constipation/ loose motion , dark color stool T. N . Acetylcysteine ACETYLCYSTEINE 600 mg 1-1-1 × 30 days Vomit, mouth sore
  • 20. PATIENT COUNSELLING: • Disease • Medication • Diet • Lifestyle modification